[1]
A. K. SHUKLA and S. MISRA, “A COMPREHENSIVE REVIEW OF MOLNUPIRAVIR, NOVEL ANTIVIRAL DRUG FOR COVID-19”, Int J Curr Pharm Sci, vol. 17, no. 3, pp. 1–6, May 2025.